Updates
Alkem Laboratories Ltd has informed BSE that some of the promoters of Alkem Laboratories Limited (Company) comprising of Mr. Samprada Singh and his lineal descendants, Mr. Balmiki Prasad Singh, Mrs. Manju Singh, Mr. Sarandhar Singh, Mr. Srinivas Singh, Mr. Satish Kumar Singh, Mrs. Premlata Singh, Mr. Sarvesh Singh, Mrs. Annapurna Singh, Mr. Sandeep Singh and Mrs. Inderjit Arora; and the Samprada Singh HUF have entered into a family settlement on... Outcome of Board Meeting
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 09, 2016, approved the Option Agreement with Mr. Tushar Kumar for grant of Option to purchase the trust units held by the Company in Avenue Venture Real Estate Fund. Fixes Record Date for Second Interim Dividend
Alkem Laboratories Ltd has informed BSE that the Company has fixed March 21, 2016 as the Record Date for the purpose of payment of Second Interim Dividend.The date of payment of Interim Dividend shall be on & from March 23, 2016. Board declares Second Interim Dividend
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 09, 2016, has declared second Interim Dividend of Rs. 9.7/- per equity share on the face value of Rs. 2/- per share for the financial year 2015-16. The date of payment of Interim Dividend shall be on & from March 23, 2016.The above said meeting of Board of Directors commenced at 11:00 A.M. and concluded at 1.00 P.M. Alkem's Mandva Plant Gets Establishment Nod from USFDA
It further said: "The facility at Mandva would be Alkem's sixth plant to receive USFDA approval." Alkem's Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA
Alkem Laboratories Ltd has informed BSE regarding a Press Release dated March 07, 2016, titled "Alkem's Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA". Board to consider Second Interim Dividend
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 09, 2016, inter alia to consider and approve second interim dividend for the Financial Year 2015-16.Further in terms of the Alkem Laboratories Limited - Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the Company shall remain closed from March... Updates
Alkem Laboratories Ltd has informed BSE regarding "Denial of news report published in "The Economic Times" - 23rd February, 2016 edition". Opening of Trading Window
With reference to earlier letter dated December 24, 2015 regarding closure of trading window (for the purpose of financial results for the quarter and nine months ended December 31, 2015) starting from December 30, 2015 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ending on December 31, 2015 communicated to the Stock Exchanges, Alkem Laboratories Ltd has now informed BSE that The Financial... Press Release and Analyst presentation on Q3FY16 Results
Alkem Laboratories Ltd has informed BSE about Press Release and Analyst presentation on Q3FY16 Results.